Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US CMS Providing Medicaid Coverage For COVID-19 Tests, But Congressman Still Sees Gaps For Testing Working Poor

Executive Summary

The US Centers for Medicare and Medicaid Services (CMS) created a new billing code to help diagnose coronavirus in its beneficiaries on 5 March, as well as fact sheets on medical care and transport of COVID-19 patients, but patients who get their health care through low-cost insurance plans may not be able to afford the testing, said a House Committee chairman.

You may also be interested in...



Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans Three COVID-19 Tests

Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.

Mayo Clinic Launches COVID-19 Test; Results Within 24 Hours

Mayo Clinic is developing a test to detect COVID-19 in the US.

NeuMoDx Molecular Launches Coronavirus Test

NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.

Related Content

Topics

UsernamePublicRestriction

Register

MT126361

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel